Rituximab for Prevention of Chronic GVHD
Clinical trial NCT00379587 · COMPLETED
Trial details
- NCT number
- NCT00379587
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2012-08-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.